MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...
Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...
Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for ...
The "Hims and Hers" commercial railed against the weight loss industry and promoted the company's weight loss drug offerings as a less costly option compared to brand-name drugs. ABC News ...
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
Patients using popular weight loss medications, such as Ozempic and Wegovy, are being urged to undergo eye examinations due ...
AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra's obesity drug. AI takes center stage at HIMSS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results